GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive: Although less is known about the direct role of GATA2 in cancer, a subset of human chronic myelogenous leukemia (CML) patients harbor two mutations in the zinc finger domain of GATA2 [112].